- Home
- 2018
Janey L. Wiggs, MD, PhD, receives ARVO Dr. David L. Epstein Award
May 9, 2018Janey L. Wiggs, MD, PhD, Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School, Associate Chief of Ophthalmology Clinical Research and Associate Director of the Howe Laboratory at Massachusetts Eye and Ear, is the 2018 recipient of the Dr.... Read More
XVIIIth International Symposium on Retinal Degeneration
April 19, 2018The XVIIIth International Symposium on Retinal Degeneration will be held in Killarney Ireland September 3rd - 8th 2018. Please visit the meeting website for details; http://www.rdmeeting.net Travel awards are offered.
Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease
March 20, 2018Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, as it is the first time any FDA-approved gene therapy has been given to a patient for any inherited disease. The treatment,... Read More
National School Walkout
March 20, 2018Some members of the OGI (including Dr. Pierce who served as the photographer) were able to join the National School Walkout this morning to remember victims of gun violence and support more stringent gun controls.
CRISPR trick in mice points the way to possible treatments for inherited diseases
March 8, 2018With the power of the genome-editing tool CRISPR on display, scientists around the world have been hard at work in recent years — developing CRISPR-based therapies that may one day edit disease-causing mutations in our DNA for the treatment of inherited disorders. But there are still great challenges with this powerful tool, and... Read More